ArticleImmunoTargets and therapy2020

Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model.

Efthymia Papaevangelou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.